Dow Jones Global Titans Portfolio, Series 46
Ticker Symbol: FCDGMX
50 Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
ABT |
Abbott Laboratories |
2% |
$117.82 |
ABBV |
AbbVie Inc. |
2% |
190.46 |
ACN |
Accenture Plc |
2% |
372.26 |
ADBE |
Adobe Incorporated |
2% |
502.54 |
GOOG |
Alphabet Inc. |
2% |
166.74 |
AMZN |
Amazon.com, Inc. |
2% |
186.89 |
AAPL |
Apple Inc. |
2% |
231.78 |
ASML |
ASML Holding N.V. |
2% |
683.52 |
AZN |
AstraZeneca Plc |
2% |
78.31 |
BHP |
BHP Group Ltd |
2% |
56.73 |
AVGO |
Broadcom Inc. |
2% |
176.82 |
CAT |
Caterpillar Inc. |
2% |
393.62 |
CVX |
Chevron Corporation |
2% |
148.73 |
CSCO |
Cisco Systems, Inc. |
2% |
56.38 |
KO |
The Coca-Cola Company |
2% |
70.57 |
CMCSA |
Comcast Corporation |
2% |
42.25 |
LLY |
Eli Lilly and Company |
2% |
916.42 |
XOM |
Exxon Mobil Corporation |
2% |
120.66 |
IBM |
International Business Machines Corporation |
2% |
233.67 |
JNJ |
Johnson & Johnson |
2% |
164.28 |
JPM |
JPMorgan Chase & Co. |
2% |
223.64 |
LIN |
Linde Plc |
2% |
483.98 |
LVMUY |
LVMH Moet Hennessy Louis Vuitton SE |
2% |
130.30 |
MA |
Mastercard Incorporated |
2% |
514.07 |
MCD |
McDonald’s Corporation |
2% |
312.92 |
MRK |
Merck & Co., Inc. |
2% |
110.42 |
META |
Meta Platforms Inc. |
2% |
576.79 |
MSFT |
Microsoft Corporation |
2% |
416.12 |
NSRGY |
Nestle S.A. |
2% |
96.76 |
NFLX |
Netflix, Inc. |
2% |
702.00 |
NVS |
Novartis AG |
2% |
116.57 |
NVO |
Novo Nordisk A/S |
2% |
118.03 |
NVDA |
NVIDIA Corporation |
2% |
135.72 |
ORCL |
Oracle Corporation |
2% |
174.77 |
PEP |
PepsiCo, Inc. |
2% |
174.48 |
PFE |
Pfizer Inc. |
2% |
29.67 |
PM |
Philip Morris International Inc. |
2% |
120.89 |
PG |
The Procter & Gamble Company |
2% |
172.38 |
RHHBY |
Roche Holding AG |
2% |
39.08 |
RY |
Royal Bank of Canada |
2% |
126.11 |
CRM |
Salesforce, Inc. |
2% |
290.86 |
SMSN LI |
Samsung Electronics Co., Ltd. |
2% |
1,092.00 |
SHEL |
Shell Plc |
2% |
66.64 |
TSM |
Taiwan Semiconductor Manufacturing Company Ltd. |
2% |
187.48 |
TSLA |
Tesla, Inc. |
2% |
221.33 |
TMO |
Thermo Fisher Scientific Inc. |
2% |
591.55 |
TTE |
TotalEnergies SE |
2% |
64.45 |
TM |
Toyota Motor Corporation |
2% |
171.50 |
UL |
Unilever Plc |
2% |
63.18 |
V |
Visa Inc. |
2% |
287.52 |
* As of the close of business on 10/16/24.
Market values are for reference only and are not indicative of your individual
cost basis.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Date of Deposit |
10/17/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
10/16/2026 |
Cash CUSIP |
30338Q284 |
Reinvestment CUSIP |
30338Q292 |
Fee Account Cash CUSIP |
30338Q300 |
Fee Account Reinvestment CUSIP |
30338Q318 |
Fee Table (based on a $10 public offering
price per unit) |
|
Standard |
Fee/Wrap |
Deferred Sales Charge |
2.25% |
— |
Creation & Development Fee (C&D Fee) |
0.50% |
0.50% |
Maximum Sales Charge |
2.75% |
0.50% |
|
|
|
Estimated Organization Costs |
0.430% |
0.430% |
Estimated Annual Trust Operating Expenses |
0.223% |
0.223% |
The deferred sales charge will be deducted in three monthly installments commencing 1/17/25. When
the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the
price exceeds $10.00 per unit, you will pay an initial sales charge. The C&D fee is a charge of $0.050 per unit
collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee
will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%.
Estimated organization costs will be deducted from the assets of the trust at the end of the initial offering
period. Estimated organization costs and trust operating expenses are assessed on a fixed dollar amount per
unit basis which, as a percentage of average net assets, will vary over time. Actual expenses may be more or
less than the estimates. Please see “Fee Table” in the trust prospectus for additional information.
You should consider the portfolio's investment objective, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the
possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in the information technology sector which involves additional risks, including limited diversification. The companies engaged in the information technology
sector are subject to fierce competition, high research and development costs, and their products and services may be subject to rapid obsolescence. Technology company stocks, especially those which are Internet-related,
may experience extreme price and volume fluctuations that are often unrelated to their operating performance.
Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.
Large capitalization companies may grow at a slower rate than the overall market.
As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant
groups in the Middle East have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions
resulting from those hostilities could have a significant impact on certain investments as well as performance.
The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.
The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.
This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.
The Dow Jones Global Titans 50TM Index is a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”)
and has been licensed for use by First Trust Portfolios L.P. Standard & Poor’s® and S&P® are registered
trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow
Jones Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed for use by SPDJI and
sublicensed for certain purposes by First Trust Portfolios L.P. The Dow Jones Global Titans Portfolio is not
sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such
parties make any representation regarding the advisability of investing in such product nor do they have any
liability for any errors, omissions, or interruptions of the Dow Jones Global Titans 50TM Index.